Prostate cancer is the second most frequently diagnosed cancer globally. A significant portion of patients who are treated have their prostate cancer come back or spread. The purpose of the Prostate Cancer Clinical Research Study is to assess if the study medicine helps prevent or slows prostate cancer from spreading to other parts of the body.
This research study is testing whether a new investigational drug that targets eosinophils (a type of white blood cell) could help patients with COPD (chronic obstructive pulmonary disease) control symptoms and reduce exacerbations (flare-ups) that lead to hospitalizations. The new investigational drug will be compared to oral and inhaled corticosteroids, the current standard of care for COPD.